Cargando…

A multicenter, randomized study to select the minimum effective dose of estetrol (E4) in postmenopausal women (E4Relief): part 1. Vasomotor symptoms and overall safety

OBJECTIVE: The aim of this study was to select the minimum effective dose of estetrol (E4) for the treatment of vasomotor symptoms in postmenopausal women. METHODS: This was a multicenter, randomized, double-blind, placebo-controlled study. Postmenopausal women (n = 257, of whom 32 were hysterectomi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaspard, Ulysse, Taziaux, Mélanie, Mawet, Marie, Jost, Maud, Gordenne, Valérie, Coelingh Bennink, Herjan J.T., Lobo, Rogerio A., Utian, Wulf H., Foidart, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott-Raven Publishers 2020
Materias:	Original Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386865/ https://www.ncbi.nlm.nih.gov/pubmed/32379217 http://dx.doi.org/10.1097/GME.0000000000001561

Ejemplares similares

A multicenter, randomized, placebo-controlled study to select the minimum effective dose of estetrol in postmenopausal participants (E4Relief): part 2—vaginal cytology, genitourinary syndrome of menopause, and health-related quality of life
por: Gaspard, Ulysse, et al.
Publicado: (2023)

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives
por: Mawet, Marie, et al.
Publicado: (2015)

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study
por: Duijkers, Ingrid J.M., et al.
Publicado: (2015)

SUN-LB001 Estetrol (E4) Is a Unique Estrogen with Selective Actions in Tissues Which Are Distinctly Different from the Actions of SERMs
por: Foidart, Jean-Michel, et al.
Publicado: (2019)

RF34 | PMON202 The Human Metabolic Profile of Estetrol
por: Gérard, Céline, et al.
Publicado: (2022)

Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone
por: Morimont, Laure, et al.
Publicado: (2022)

The benefits of estetrol addition to drospirenone for contraception
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Tumor suppression, dose-limiting toxicity and wellbeing with the fetal estrogen estetrol in patients with advanced breast cancer
por: Schmidt, Marcus, et al.
Publicado: (2020)

Reply to Bexultan Kazybay and Yingqiu Xie’s Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Estetrol Is Safe and Well Tolerated during Treatment of Hospitalized Men and Women with Moderate COVID-19 in a Randomized, Double-Blind Study
por: Foidart, Jean Michel, et al.
Publicado: (2023)

Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review
por: Utian, Wulf H
Publicado: (2005)

Pro-Apoptotic Effects of Estetrol on Long-Term Estrogen-Deprived Breast Cancer Cells and at Low Doses on Hormone-Sensitive Cells
por: Yue, Wei, et al.
Publicado: (2019)

Response to paper by Binkowska et al. Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings. Commentary: Oestradiol is not the holy grail in the quest for the ideal oestrogen therapy
por: Douxfils, Jonathan, et al.
Publicado: (2023)

Estetrol Combined to Progestogen for Menopause or Contraception Indication Is Neutral on Breast Cancer
por: Gallez, Anne, et al.
Publicado: (2021)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study
por: Zimmerman, Yvette, et al.
Publicado: (2022)

Comparison of Estetrol Exposure between Women and Mice to Model Preclinical Experiments and Anticipate Human Treatment
por: Gallez, Anne, et al.
Publicado: (2023)

Estetrol and Mammary Gland: Friends or Foes?
por: Gallez, Anne, et al.
Publicado: (2021)

Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2022)

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
por: Coelingh Bennink, Herjan J.T., et al.
Publicado: (2021)

Estetrol: From Preclinical to Clinical Pharmacology and Advances in the Understanding of the Molecular Mechanism of Action
por: Gérard, Céline, et al.
Publicado: (2023)

Target expression is a relevant factor in synthetic lethal screens
por: Schultz, Iman J., et al.
Publicado: (2022)

An Oral Contraceptive Containing Estetrol 15 MG and Drospirenone 3 MG Has Limited Effects on Endocrine and Metabolic Parameters
por: Klipping, Christine, et al.
Publicado: (2021)

Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

The Effect of Estetrol/Drospirenone on Ovarian Function Is Similar to a Well-Established Combined Oral Contraceptive: Results From a Phase 2 Study
por: Duijkers, Ingrid J M, et al.
Publicado: (2021)

Use of estetrol with other steroids for attenuation of neonatal hypoxic-Ischemic brain injury: to combine or not to combine?
por: Tskitishvili, Ekaterine, et al.
Publicado: (2016)

Estetrol: A New Choice for Contraception
por: Fruzzetti, Franca, et al.
Publicado: (2021)

Effects of E2/P4 oral capsules on bone turnover in women with vasomotor symptoms
por: McClung, Michael R., et al.
Publicado: (2022)

Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial
por: Mawet, Marie, et al.
Publicado: (2014)

Estetrol‐Drospirenone combination oral contraceptive: a clinical study of contraceptive efficacy, bleeding pattern and safety in Europe and Russia
por: Gemzell‐Danielsson, K, et al.
Publicado: (2021)

Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Correction: Estetrol/Drospirenone: A Review in Oral Contraception
por: Lee, Arnold, et al.
Publicado: (2022)

Hormonal therapies and venous thrombosis: Estrogen matters!
por: Morimont, Laure, et al.
Publicado: (2023)

Hormonal therapies and venous thrombosis: considerations for prevention and management—a reappraisal
por: Douxfils, Jonathan, et al.
Publicado: (2023)

SAT-021 Effects of E2/P4 Oral Capsules on Bone Turnover in Women with Vasomotor Symptoms
por: Constantine, Ginger, et al.
Publicado: (2020)

SAT-001 Clinically Meaningful Effects of E2/P4 Oral Capsule in Treating Vasomotor Symptoms
por: Constantine, Ginger, et al.
Publicado: (2020)

Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms
por: Gérard, Céline, et al.
Publicado: (2015)

Commentary on guidelines on postmenopausal osteoporosis - Indian Menopause Society
por: Utian, Wulf H.
Publicado: (2013)

Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells
por: Montt-Guevara, Maria Magdalena, et al.
Publicado: (2015)

Pharmacy Compounding Primer for Physicians: Prescriber Beware
por: Sellers, Sarah, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_anmooae8cqgtda2tcmaj77bkje